HealthySole® ROI

Both the Centers for Disease Control and Prevention (CDC) and American Journal of Infection Control strongly acknowledge that the cost and burden of HAI’s in the healthcare arena heavily outweighs the costs of multifaceted HAI prevention programs. If investments toward these programs and new technologies do not become a focus, the costs both financially and to human well-being will continue to grow.

Currently, HAI’s are one of the leading killers in the U.S. with nearly 100,000 people dying each year. The estimated overall direct annual cost of HAI’s ranges from $35-$45 billion. Several studies relating to the cost burden of HAI’s in hospitals, suggest that the average costs exceed $15,000 and can significantly increase upwards of $150,000 per patient.

Many studies have confirmed that shoes are a major reservoir of infectious microrgansisms. Implementing HealthySole® should be the first step in killing the shoeborne infectious organisms traveling into and throughout any healthcare environment. Controlling the spread of shoeborne pathogens will reduce the overall microbial load that directly impacts the number of HAI’s within any healthcare facility. The HealthySole® significantly reduces the amount of dangerous pathogens carried on the soles of shoes in just 8 seconds. According to the CDC and NIOSH (National Institute for Occupational Safety and Health), once these pathogens are transmitted from the soles of your shoes to the floors of a facility, they become infectious aerosols. (Baron)

Generation and Behavior of Airborne Particles (Aerosols)

With the relatively low cost of each unit, the return on investment for the implementation of the HealthySole® Technology is fast and significant! The cost to treat one HAI can be equal to the cost of 4 to 40 HealthySole® units!